Comparison of work productivity losses in the United States among employees with COVID-19 at high-risk of severe disease who were untreated or treated with nirmatrelvir/ritonavir.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/41389193

Brenna L Brady; Emmanuel F Drabo; Frank R Ernst; Gurinder S Sidhu; Joseph C Cappelleri; Kristin A Evans; María M Fernández; Mohammad A Chaudhary; Paul Cislo; Ruth Mokgokong

Dec 14, 2025